Regenerative Medical Technology (RMTG) Operating Margin (2018 - 2025)
Historic Operating Margin for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to 37.76%.
- Regenerative Medical Technology's Operating Margin fell 397500.0% to 37.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.58%, marking a year-over-year increase of 99500.0%. This contributed to the annual value of 1.98% for FY2024, which is 316500.0% up from last year.
- According to the latest figures from Q3 2025, Regenerative Medical Technology's Operating Margin is 37.76%, which was down 397500.0% from 25.43% recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Operating Margin ranged from a high of 25.19% in Q4 2024 and a low of 5462.49% during Q3 2021
- In the last 5 years, Regenerative Medical Technology's Operating Margin had a median value of 37.76% in 2025 and averaged 617.31%.
- In the last 5 years, Regenerative Medical Technology's Operating Margin tumbled by -50663700bps in 2021 and then skyrocketed by 54185200bps in 2022.
- Regenerative Medical Technology's Operating Margin (Quarter) stood at 196.56% in 2021, then tumbled by -121bps to 433.93% in 2022, then surged by 95bps to 21.95% in 2023, then soared by 215bps to 25.19% in 2024, then plummeted by -250bps to 37.76% in 2025.
- Its Operating Margin stands at 37.76% for Q3 2025, versus 25.43% for Q2 2025 and 9.89% for Q1 2025.